DEUS附着点炎指数(DEI):一种整合超声与临床检查评估脊柱关节炎附着点炎的新工具
该多中心横断面观察性研究在11个国家20个风湿病中心对413例脊柱关节炎患者(中轴型224例、银屑病关节炎189例)双侧下肢大附着点行超声与临床检查,构建整合两者评分的DEI(总分0–20分)。DEI与疾病活动度及严重度指标相关,但对C反应蛋白和超声结构损伤的拟合优于单独临床检查,而单独临床检查对疾病活动度及患者报告结局的拟合优于DEI。
要点
- DEI整合超声与临床附着点炎评估,每例总分0–20分,患者中位DEI为1.0(IQR 0.0–3.0)。
- DEI与脊柱关节炎疾病活动度及严重度指标相关,但银屑病关节炎患者中与DAPSA评分无关。
- DEI对C反应蛋白及超声结构损伤的拟合优于单独临床检查。
核心结论
- DEI是一种整合超声与临床检查评估附着点炎的新工具,可能为脊柱关节炎该核心领域的评估提供更可靠的手段。
研究设计与样本
- 横断面、观察性、多中心研究,纳入11个国家20个风湿病中心的413例脊柱关节炎患者,其中中轴型脊柱关节炎224例、银屑病关节炎189例。
主要发现
- 脊柱关节炎患者中位DEI为1.0(IQR 0.0–3.0)。
- 回归分析中DEI与脊柱关节炎疾病活动度及严重度指数显著相关,但银屑病关节炎患者中与银屑病关节炎疾病活动度(DAPSA)评分例外。
- 与单独临床检查相同附着点相比,DEI模型对C反应蛋白水平及超声检测的附着点结构损伤(附着点骨赘和骨侵蚀)的拟合显著更优。
- 相反,单独临床检查模型对脊柱关节炎疾病活动度指数及患者报告结局的拟合显著优于DEI。
关键数值与推荐
- 每个附着点临床附着点炎计1.0分、超声附着点炎计1.0分,共评估10个附着点。
- 每例患者DEI总分整合临床与超声结果,范围为0–20分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: (1) To develop a composite score, the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) Enthesitis Index (DEI), which integrates ultrasound and clinical examination findings for enthesitis assessment in patients with spondyloarthritis (SpA); (2) to examine the relationships between DEI and clinical features in this population, compared to the clinical examination of the entheses alone. METHODS: This was a cross-sectional, observational, multicentric study involving 20 rheumatology centres across 11 countries. Ultrasound and clinical examinations were performed bilaterally on the lower limb large entheses (ie, quadriceps tendon, proximal and distal patellar tendons, Achilles tendon and plantar fascia) in 413 patients with SpA, including 224 patients with axial SpA and 189 patients with psoriatic arthritis (PsA). A score of 1.0 for clinical enthesitis and 1.0 for ultrasound enthesitis was assigned for each of the 10 entheses evaluated. The total DEI score, which combines clinical and ultrasound findings, ranged from 0 to 20 per patient. Logistic and gamma regression models based on DEI were compared with those derived solely from clinical enthesitis assessment to evaluate their relative performance in explaining disease-related outcomes. RESULTS: Among patients with SpA, the median DEI was 1.0 (IQR 0.0-3.0). DEI showed significant associations with SpA disease activity and severity indices in regression analyses, except for the Disease Activity in Psoriatic Arthritis score in patients with PsA. Compared with the clinical examination alone of the same entheses, DEI models exhibited a significantly better fit with C-reactive protein levels and ultrasound-detected structural damage at the enthesis (ie, enthesophytes and bone erosions). By contrast, the clinical examination alone models showed a significantly stronger fit with SpA disease activity indices and patient-reported outcomes compared with the DEI. CONCLUSIONS: DEI is a novel tool that integrates both ultrasound and clinical examination findings for enthesitis assessment, potentially ensuring a more reliable evaluation of this key domain in SpA.
引用
- Di Matteo A, Di Donato S, Filippucci E, et al. DEUS Enthesitis Index (DEI): a new tool integrating ultrasound and clinical examination for enthesitis assessment in spondyloarthritis. RMD Open. 2025. PMID: 40295120. doi:10.1136/rmdopen-2025-005496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。